Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other Non-Current Assets (2016 - 2025)

Standard Biotools has reported Other Non-Current Assets over the past 16 years, most recently at $3.5 million for Q3 2025.

  • Quarterly Other Non-Current Assets fell 24.12% to $3.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Sep 2025, down 24.12% year-over-year, with the annual reading at $3.6 million for FY2024, 55.36% up from the prior year.
  • Other Non-Current Assets was $3.5 million for Q3 2025 at Standard Biotools, down from $223.1 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $223.1 million in Q2 2025 and troughed at $1.0 million in Q2 2021.
  • The 5-year median for Other Non-Current Assets is $3.5 million (2025), against an average of $15.1 million.
  • Year-over-year, Other Non-Current Assets crashed 79.82% in 2021 and then soared 5109.93% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.7 million in 2021, then decreased by 15.72% to $3.1 million in 2022, then dropped by 26.5% to $2.3 million in 2023, then skyrocketed by 55.36% to $3.6 million in 2024, then dropped by 0.82% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Other Non-Current Assets are $3.5 million (Q3 2025), $223.1 million (Q2 2025), and $6.5 million (Q1 2025).